{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:43:28Z","timestamp":1792086208327,"version":"4.4.0"},"reference-count":271,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>\n                    Primary\n                    <jats:named-content content-type=\"genus-species\">Toxoplasma gondii<\/jats:named-content>\n                    infection is usually subclinical, but cervical lymphadenopathy or ocular disease can be present in some patients. Active infection is characterized by tachyzoites, while tissue cysts characterize latent disease.\n                  <\/jats:p>","DOI":"10.1128\/cmr.00057-17","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T09:30:20Z","timestamp":1536658220000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":500,"title":["Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice"],"prefix":"10.1128","volume":"31","author":[{"given":"Ildiko Rita","family":"Dunay","sequence":"first","affiliation":[{"name":"Institute of Inflammation and Neurodegeneration, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Gajurel","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshika","family":"Dhakal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Liesenfeld","sequence":"additional","affiliation":[{"name":"Institute for Microbiology and Hygiene, Charit\u00e9 Medical School, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Montoya","sequence":"additional","affiliation":[{"name":"Palo Alto Medical Foundation Toxoplasma Serology Laboratory, Palo Alto, California, USA"},{"name":"Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16412-X"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/521246"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv177"},{"key":"e_1_3_2_5_2","first-page":"65","volume-title":"Recent research developments in antimicrobial agents and chemotherapy","author":"Khan AA","year":"1996","unstructured":"Khan AA, Araujo FG. 1996. Recent developments in the search for therapeutic interventions against Toxoplasma gondii infection, p 65\u201377. In Recent research developments in antimicrobial agents and chemotherapy, vol 1. Research Signpost, Thiruvananthapuram, Kerala, India."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1953.2.429"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1956.tb36617.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S60973"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01176-16"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2012.660479"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2012.729036"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00025"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2016-0039"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-51-13809"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1970.19.422"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1949.s1-29.889"},{"key":"e_1_3_2_17_2","first-page":"483","article-title":"Synergistic effect of sulfadiazine and daraprim against experimental toxoplasmosis in the mouse","volume":"3","author":"Eyles DE","year":"1953","unstructured":"Eyles DE, Coleman N. 1953. Synergistic effect of sulfadiazine and daraprim against experimental toxoplasmosis in the mouse. Antibiot Chemother (Northfield) 3:483\u2013490.","journal-title":"Antibiot Chemother (Northfield)"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1957.tb00119.x"},{"key":"e_1_3_2_19_2","first-page":"957","article-title":"Spiramycin therapy of experimental toxoplasmosis in mice","volume":"66","author":"Garin JP","year":"1958","unstructured":"Garin JP, Eyles DE. 1958. Spiramycin therapy of experimental toxoplasmosis in mice. Presse Med 66:957\u2013958.","journal-title":"Presse Med"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/590149"},{"key":"e_1_3_2_21_2","first-page":"988","article-title":"Notes on the treatment of acute experimental toxoplasmosis of the mouse with chlortetracycline and tetracycline","volume":"4","author":"Eyles DE","year":"1954","unstructured":"Eyles DE, Coleman N. 1954. Notes on the treatment of acute experimental toxoplasmosis of the mouse with chlortetracycline and tetracycline. Antibiot Chemother (Northfield) 4:988\u2013991.","journal-title":"Antibiot Chemother (Northfield)"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-135-35011"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1973.22.14"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.17-0677"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1701.P11101"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.11.4037-4044.2002"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03648.x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2009.11.015"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1951.tb17165.x"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-44-3-557"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(53)90047-3"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195712262572601"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2016.10.007"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens6020019"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.12100234"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608310104"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12423"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-017-5478-y"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212033272306"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03350070031018"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90151-3"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90378-1"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291403"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01967063"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-1-33"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.10.2049"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964458"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91997-9"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1346"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90014-9"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02230867"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.2.268"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1988.00380110109023"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.1990.11718072"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200406180-00016"},{"key":"e_1_3_2_56_2","first-page":"51","article-title":"Oral trimethoprim-sulfamethoxazole in the treatment of cerebral toxoplasmosis in AIDS patients\u2014a prospective study","volume":"94","author":"Francis P","year":"2004","unstructured":"Francis P, Patel VB, Bill PL, Bhigjee AI. 2004. Oral trimethoprim-sulfamethoxazole in the treatment of cerebral toxoplasmosis in AIDS patients\u2014a prospective study. S Afr Med J 94:51\u201353.","journal-title":"S Afr Med J"},{"key":"e_1_3_2_57_2","first-page":"956","article-title":"Treating AIDS-associated cerebral toxoplasmosis-pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids","volume":"97","author":"Arens J","year":"2007","unstructured":"Arens J, Barnes K, Crowley N, Maartens G. 2007. Treating AIDS-associated cerebral toxoplasmosis-pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids. S Afr Med J 97:956\u2013958.","journal-title":"S Afr Med J"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2009.80.583"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1177\/1545109707301244"},{"key":"e_1_3_2_60_2","first-page":"CD005420","article-title":"Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)","volume":"2006","author":"Dedicoat M","year":"2006","unstructured":"Dedicoat M, Livesley N. 2006. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings). Cochrane Database Syst Rev 2006:CD005420.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1179\/2047773213Y.0000000094"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12402"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138204"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2013.05.006"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.3.422"},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1086\/339551","article-title":"Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237\/ANRS 039 Study. AIDS Clinical Trials Group 237\/Agence Nationale de Recherche sur le SIDA, Essai 039","volume":"34","author":"Chirgwin K","year":"2002","unstructured":"Chirgwin K, Hafner R, Leport C, Remington J, Andersen J, Bosler EM, Roque C, Rajicic N, McAuliffe V, Morlat P, Jayaweera DT, Vilde JL, Luft BJ. 2002. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237\/ANRS 039 Study. AIDS Clinical Trials Group 237\/Agence Nationale de Recherche sur le SIDA, Essai 039. Clin Infect Dis 34:1243\u20131250.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_2_67_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1086\/520141","article-title":"A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"29","author":"Cohn DL","year":"1999","unstructured":"Cohn DL, Fisher EJ, Peng GT, Hodges JS, Chesnut J, Child CC, Franchino B, Gibert CL, El-Sadr W, Hafner R, Korvick J, Ropka M, Heifets L, Clotfelter J, Munroe D, Horsburgh CR, Jr. 1999. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis 29:125\u2013133.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200103300-00007"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02000407"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199006000-00003"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1086\/504872"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01459.x"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-4-200208200-00008"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1086\/338816"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964427"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-3-199508010-00003"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050436"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv235"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.199919"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2005.19.626"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2016.1273597"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2011.10-0718"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.05.018"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2017.1377974"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02306491"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964460"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-10-760"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000169"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-013-1379-8"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1086\/426447"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1086\/651266"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03282-14"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw330"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703425"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.02091.x"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir806"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000188183.49025.d5"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2015.06.016"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12853"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfr139"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.Supplement_2.S423"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-013-1879-8"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw070"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.029"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197405162902003"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90785-3"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2015.02.015"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2015.02.017"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)00990-9"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-010-1379-9"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-306650"},{"key":"e_1_3_2_112_2","first-page":"867","article-title":"Diagnosis and treatment of toxoplasmic uveitis","volume":"58","author":"Culligan JJ","year":"1954","unstructured":"Culligan JJ, Gunkel RD, Jacobs L, Cook MK. 1954. Diagnosis and treatment of toxoplasmic uveitis. Trans Am Acad Ophthalmol Otolaryngol 58:867\u2013884.","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(56)90925-4"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1962.00960020712004"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)74456-3"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.40.10.577"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1964.00970010074010"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1964.00970010899023"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(80)35268-8"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(83)90378-1"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.01.028"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.3928\/1542-8877-20010501-03"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31804b3f0d"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006129422690"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.04.020"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-012-9634-1"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01663-15"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.05.025"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1359307"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1307420"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20150101-27"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90021-0"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.882735"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.11.1306"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joco.2016.10.002"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00083-6"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01526-X"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.07.061"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002218.pub2"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004892"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01527-1"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.12.022"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.08.003"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000205"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007417.pub2"},{"key":"e_1_3_2_146_2","first-page":"639","article-title":"The treatment of toxoplasmic uveitis","volume":"10","author":"Gordon DM","year":"1970","unstructured":"Gordon DM. 1970. The treatment of toxoplasmic uveitis. Int Ophthalmol Clin 10:639\u2013646.","journal-title":"Int Ophthalmol Clin"},{"key":"e_1_3_2_147_2","first-page":"811","article-title":"Results of treatment of ocular toxoplasmosis with injectable corticosteroids","volume":"83","author":"Nozik RA","year":"1977","unstructured":"Nozik RA. 1977. Results of treatment of ocular toxoplasmosis with injectable corticosteroids. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 83:811\u2013818.","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.8.858"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.155861"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007417.pub3"},{"key":"e_1_3_2_151_2","first-page":"146","article-title":"Toxoplasmosis in pregnancy and its transmission to the fetus","volume":"50","author":"Desmonts G","year":"1974","unstructured":"Desmonts G, Couvreur J. 1974. Toxoplasmosis in pregnancy and its transmission to the fetus. Bull N Y Acad Med 50:146\u2013159.","journal-title":"Bull N Y Acad Med"},{"key":"e_1_3_2_152_2","first-page":"166","article-title":"Prognosis of pregnancy in patients with toxoplasmic retinochoroiditis","volume":"27","author":"Oniki S","year":"1983","unstructured":"Oniki S. 1983. Prognosis of pregnancy in patients with toxoplasmic retinochoroiditis. Jpn J Ophthalmol 27:166\u2013174.","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00302.x"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2005.01061.x"},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.5.1055"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1998.tb00527.x"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08220-8"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-0328(02)02325-X"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/30.6.1303"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis234"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit032"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000351"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2014.09.018"},{"key":"e_1_3_2_164_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60072-5"},{"key":"e_1_3_2_165_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198802043180502"},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92298-5"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.199.2.8668790"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7197.1511"},{"key":"e_1_3_2_169_2","first-page":"CD001684","article-title":"Treatments for toxoplasmosis in pregnancy","volume":"2000","author":"Peyron F","year":"2000","unstructured":"Peyron F, Wallon M, Liou C, Garner P. 2000. Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev 2000:CD001684.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_170_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70311-X"},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2005.tb01844.x"},{"key":"e_1_3_2_172_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/30.6.1309"},{"key":"e_1_3_2_173_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318134286d"},{"key":"e_1_3_2_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.05.031"},{"key":"e_1_3_2_175_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3860"},{"key":"e_1_3_2_176_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-008-0612-5"},{"key":"e_1_3_2_177_2","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2014.161"},{"key":"e_1_3_2_178_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182343096"},{"key":"e_1_3_2_179_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005222"},{"key":"e_1_3_2_180_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.66.5.767"},{"key":"e_1_3_2_181_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.06.022"},{"key":"e_1_3_2_182_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406303302604"},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.1086\/501360"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.1.38"},{"key":"e_1_3_2_185_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001120"},{"key":"e_1_3_2_186_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu721"},{"key":"e_1_3_2_187_2","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2017.1370528"},{"key":"e_1_3_2_188_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.07.031"},{"key":"e_1_3_2_189_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.33.30317"},{"key":"e_1_3_2_190_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001333"},{"key":"e_1_3_2_191_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005648"},{"key":"e_1_3_2_192_2","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/1995023243"},{"key":"e_1_3_2_193_2","first-page":"83","article-title":"Isolation of toxoplasma from experimental pigs medicated with sulfamonomethoxine","volume":"6","author":"Tsunoda K","year":"1966","unstructured":"Tsunoda K, Suzuki K, Ito S, Tsutsumi Y. 1966. Isolation of toxoplasma from experimental pigs medicated with sulfamonomethoxine. Natl Inst Anim Health Q (Tokyo) 6:83\u201388.","journal-title":"Natl Inst Anim Health Q (Tokyo)"},{"key":"e_1_3_2_194_2","doi-asserted-by":"publisher","DOI":"10.1111\/apm.1966.68.4.605"},{"key":"e_1_3_2_195_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1985.34.50"},{"key":"e_1_3_2_196_2","doi-asserted-by":"publisher","DOI":"10.1556\/1886.2015.00045"},{"key":"e_1_3_2_197_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00992.x"},{"key":"e_1_3_2_198_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0147-9571(96)00038-0"},{"key":"e_1_3_2_199_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4017(97)00227-6"},{"key":"e_1_3_2_200_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpa.2017.04.003"},{"key":"e_1_3_2_201_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005434"},{"key":"e_1_3_2_202_2","doi-asserted-by":"publisher","DOI":"10.1086\/338006"},{"key":"e_1_3_2_203_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.9.2067"},{"key":"e_1_3_2_204_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.8.1467"},{"key":"e_1_3_2_205_2","doi-asserted-by":"publisher","DOI":"10.2307\/4588050"},{"key":"e_1_3_2_206_2","first-page":"937","article-title":"Pyrimethamine (daraprim) in therapy of human toxoplasmosis","volume":"94","author":"Petrovicky O","year":"1955","unstructured":"Petrovicky O, Styblova V. 1955. Pyrimethamine (daraprim) in therapy of human toxoplasmosis. Cas Lek Cesk 94:937\u2013939.","journal-title":"Cas Lek Cesk"},{"key":"e_1_3_2_207_2","first-page":"486","article-title":"Meningoencephalitis toxoplasmatica acuta cured with pyrimethamine","volume":"94","author":"Petrovicky O","year":"1955","unstructured":"Petrovicky O. 1955. Meningoencephalitis toxoplasmatica acuta cured with pyrimethamine. Cas Lek Cesk 94:486\u2013490.","journal-title":"Cas Lek Cesk"},{"key":"e_1_3_2_208_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1957.tb00118.x"},{"key":"e_1_3_2_209_2","first-page":"731","article-title":"The chemotherapeutic effect of pyrimethamine and sulfadiazine on toxoplasmosis of the Norway rat","volume":"5","author":"Eyles DE","year":"1955","unstructured":"Eyles DE, Jones FE. 1955. The chemotherapeutic effect of pyrimethamine and sulfadiazine on toxoplasmosis of the Norway rat. Antibiot Chemother (Northfield) 5:731\u2013734.","journal-title":"Antibiot Chemother (Northfield)"},{"key":"e_1_3_2_210_2","first-page":"529","article-title":"An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis","volume":"5","author":"Eyles DE","year":"1955","unstructured":"Eyles DE, Coleman N. 1955. An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis. Antibiot Chemother (Northfield) 5:529\u2013539.","journal-title":"Antibiot Chemother (Northfield)"},{"key":"e_1_3_2_211_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1960.03020310059017"},{"key":"e_1_3_2_212_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1964.00970020084019"},{"key":"e_1_3_2_213_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1978.27.747"},{"key":"e_1_3_2_214_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.2.252"},{"key":"e_1_3_2_215_2","first-page":"107","article-title":"A acao terapeutica de alguns compostos sulfanilamidicos na infeccao experimental por Toxoplasma","volume":"26","author":"Biocca E","year":"1942","unstructured":"Biocca E, Pasqualin R. 1942. A acao terapeutica de alguns compostos sulfanilamidicos na infeccao experimental por Toxoplasma. Arq Inst Biol (Sao Paulo) 26:107\u2013109.","journal-title":"Arq Inst Biol (Sao Paulo)"},{"key":"e_1_3_2_216_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1983.tb10537.x"},{"key":"e_1_3_2_217_2","doi-asserted-by":"publisher","DOI":"10.1556\/EuJMI.1.2011.3.9"},{"key":"e_1_3_2_218_2","first-page":"150","article-title":"Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations","volume":"78","author":"Seah SK","year":"1975","unstructured":"Seah SK. 1975. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations. J Trop Med Hyg 78:150\u2013153.","journal-title":"J Trop Med Hyg"},{"key":"e_1_3_2_219_2","first-page":"25","article-title":"A comparison of Ultrax, diazil, Bactrim and spiramycin in experimental toxoplasmosis in mice (author's translation)","volume":"90","author":"Coradello H","year":"1978","unstructured":"Coradello H, Kretschmer S. 1978. A comparison of Ultrax, diazil, Bactrim and spiramycin in experimental toxoplasmosis in mice (author's translation). Wien Klin Wochenschr 90:25\u201329.","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_3_2_220_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2004.09.015"},{"key":"e_1_3_2_221_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05183-11"},{"key":"e_1_3_2_222_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.1.26"},{"key":"e_1_3_2_223_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.1.14"},{"key":"e_1_3_2_224_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(98)00064-8"},{"key":"e_1_3_2_225_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.3.550"},{"key":"e_1_3_2_226_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.9.2240"},{"key":"e_1_3_2_227_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.2.293"},{"key":"e_1_3_2_228_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.2.326"},{"key":"e_1_3_2_229_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.11.2371"},{"key":"e_1_3_2_230_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.2.494"},{"key":"e_1_3_2_231_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf251"},{"key":"e_1_3_2_232_2","doi-asserted-by":"publisher","DOI":"10.1645\/GE-250R"},{"key":"e_1_3_2_233_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.2006.00217.x"},{"key":"e_1_3_2_234_2","doi-asserted-by":"publisher","DOI":"10.1645\/13-451.1"},{"key":"e_1_3_2_235_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2005.12.006"},{"key":"e_1_3_2_236_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1208069109"},{"key":"e_1_3_2_237_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01683-15"},{"key":"e_1_3_2_238_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00760"},{"key":"e_1_3_2_239_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01192"},{"key":"e_1_3_2_240_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.342.6165.1432"},{"key":"e_1_3_2_241_2","first-page":"528","article-title":"The effect of chemo-immunotherapy with SDDS, pyrimethamine and anti-Toxoplasma serum on Toxoplasma gondii cysts in latent infected NMRI mice","volume":"28","author":"Werner H","year":"1977","unstructured":"Werner H, Masihi KN, Tischer I, Adusu E. 1977. The effect of chemo-immunotherapy with SDDS, pyrimethamine and anti-Toxoplasma serum on Toxoplasma gondii cysts in latent infected NMRI mice. Tropenmed Parasitol 28:528\u2013532.","journal-title":"Tropenmed Parasitol"},{"key":"e_1_3_2_242_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.8.1672"},{"key":"e_1_3_2_243_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.5.1639-1642.1994"},{"key":"e_1_3_2_244_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312233292604"},{"key":"e_1_3_2_245_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.3.653"},{"key":"e_1_3_2_246_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.5.1068"},{"key":"e_1_3_2_247_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2013.12.005"},{"key":"e_1_3_2_248_2","first-page":"1171","article-title":"Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease","volume":"39","author":"Gormley PD","year":"1998","unstructured":"Gormley PD, Pavesio CE, Minnasian D, Lightman S. 1998. Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease. Invest Ophthalmol Vis Sci 39:1171\u20131175.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_249_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1974.01010010252017"},{"key":"e_1_3_2_250_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.6.1352"},{"key":"e_1_3_2_251_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(82)90541-4"},{"key":"e_1_3_2_252_2","doi-asserted-by":"publisher","DOI":"10.1645\/GE-1765.1"},{"key":"e_1_3_2_253_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.5.6.647"},{"key":"e_1_3_2_254_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.1.137"},{"key":"e_1_3_2_255_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.9.1930"},{"key":"e_1_3_2_256_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.149.1.175","article-title":"Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii","volume":"149","author":"Gazzinelli R","year":"1992","unstructured":"Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A. 1992. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 149:175\u2013180.","journal-title":"J Immunol"},{"key":"e_1_3_2_257_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.9.3050-3055.1990"},{"key":"e_1_3_2_258_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004360050258"},{"key":"e_1_3_2_259_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-46-3-263"},{"key":"e_1_3_2_260_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198605000-00012"},{"key":"e_1_3_2_261_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004360050185"},{"key":"e_1_3_2_262_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-013-3488-y"},{"key":"e_1_3_2_263_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.4.569"},{"key":"e_1_3_2_264_2","doi-asserted-by":"publisher","DOI":"10.1080\/08830180213281"},{"key":"e_1_3_2_265_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2007.09.004"},{"key":"e_1_3_2_266_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(00)00318-X"},{"key":"e_1_3_2_267_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1771-1779.2001"},{"key":"e_1_3_2_268_2","doi-asserted-by":"publisher","DOI":"10.3109\/10611861003733995"},{"key":"e_1_3_2_269_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.12.4848-4854.2004"},{"key":"e_1_3_2_270_2","doi-asserted-by":"publisher","DOI":"10.1080\/10611860902718680"},{"key":"e_1_3_2_271_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi048080x"},{"key":"e_1_3_2_272_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00502-09"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00057-17","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00057-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T21:00:09Z","timestamp":1693861209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CMR.00057-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":271,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1128\/CMR.00057-17"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00057-17","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"2018-09-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00057-17"}}